The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.80
Bid: 165.60
Ask: 166.00
Change: 1.00 (0.61%)
Spread: 0.40 (0.242%)
Open: 166.00
High: 167.80
Low: 164.00
Prev. Close: 164.80
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

31 Aug 2023 07:00

RNS Number : 8535K
C&C Group Plc
31 August 2023
 

 

 

 

Directorate Changes

 

Chris Browne OBE and Sarah Newbitt appointed Independent Non-Executive Directors

 

Dublin, London | 31 August 2023: C&C Group plc ('C&C' or the 'Group'), a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits and soft drinks across the UK and Ireland, is pleased to announce the appointments of Chris Browne OBE and Sarah Newbitt as independent Non-Executive Directors.

 

The appointments of Chris, effective 2 October, and Sarah, effective today, follow a thorough recruitment process led by the Nomination Committee, with the support of an independent executive search firm. Chris brings vast experience managing complex consumer-facing operations to C&C, while Sarah brings extensive consumer goods sector and supply chain expertise, together with developing and implementing sustainability strategies.

 

Chris Browne OBE

Chris Browne has held a number of senior leadership and executive roles within the aviation and travel industries. Chris first served as Managing Director of First Choice Airways, which included overseeing a customer-focused transformation programme. She subsequently directed and managed a successful merger with Thomson Airways before being appointed to execute a similar project for parent company, TUI Group plc. In 2016, Chris joined EasyJet plc and served as Chief Operating Officer until 2019.

 

Chris is currently a Non-Executive Director of UK homebuilders, Vistry Group plc, infrastructure, construction and property development services business, Kier Group plc and Constellium, a NYSE-listed aluminium products manufacturer headquartered in Paris. Chris has a Doctorate of Science (Honorary) for Leadership in Management and was awarded an OBE for services to aviation in 2013.

 

Sarah Newbitt

Sarah Newbitt spent the majority of her executive career with Unilever, one of the world's largest consumer goods companies. Over the course of 25 years in Unilever, Sarah held various international roles across operations and general management, and gained substantial M&A integration experience. Her most recent role was as Vice President Supply Chain of Unilever UK & Ireland, a £2bn turnover business employing over 6,000 people.

 

Sarah is currently a Non-Executive Director of Ellab A/S, a Danish validation and monitoring solutions provider, and a Non-Executive Director and Chair of the Remuneration Committee of High Value Manufacturing Catapult, a group of research, development and innovation centres transforming UK manufacturing.

 

Ralph Findlay, C&C Group Executive Chair, commented: "We are delighted to welcome Chris and Sarah to the Board and look forward to drawing on their diverse and extensive public company expertise across operations, logistics, international consumer goods, supply chain management and sustainability, for the benefit of the Group in the years ahead."

 

Chris Browne OBE, commented: "With its iconic brands and leading distribution platform, I'm excited to join the Board of C&C and look forward to sharing my expertise and contributing to the next phase of development for the Group."

 

Sarah Newbitt, commented: "I am pleased to be joining the Board of C&C and contributing to the company's future strategy and growth, especially in the areas of operations and sustainability."

 

This announcement is made in accordance with Listing Rule 9.6.11 and there is no further information to be disclosed pursuant to Listing Rule 9.6.13.

 

 

ENDS

 

 

Contacts

 

C&C Group plcRiona Heffernan, Finance and Investor Relations DirectorEmail: riona.heffernan@candcgroup.ie  

 

UK & International Media Richard HayhoeEmail: richard.hayhoe@candcgroup.com

 

Investors, Analysts & Irish MediaFTI Consulting Jonathan Neilan / Paddy Berkery / Aline OliveiraTel: +353 86 231 4135 / +353 86 6025988 / +353 83 8331644Email: CandCGroup@fticonsulting.com

 

 

About C&C Group plc

 

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

• C&C Group's portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent's, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.

• C&C Group has owned brand and contract manufacturing/packing operations in Co. Tipperary, Ireland and Glasgow, Scotland.

• C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

 

C&C Group is a FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange (LSE: CCR)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKKBPPBKDAFN
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20244:30 pmRNSDirector/PDMR Shareholding
16th Apr 202410:30 amRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20245:15 pmRNSTotal Voting Rights and Capital
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20243:25 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20242:55 pmRNSTotal Voting Rights and Capital
22nd Feb 20245:31 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSLaunch of EUR 15 Million Share Buyback Programme
15th Feb 20246:00 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.